6550--629-26-1-042-0000 FISHER IMMUNOSUPPRESSANT (VA-26-00014575)
| Agency: | VETERANS AFFAIRS, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Oct 17, 2025 |
| Due Date: | Oct 27, 2025 |
| Solicitation No: | 36C25626Q0083 |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
Follow
Active
Contract Opportunity
Notice ID
36C25626Q0083
Related Notice
Department/Ind. Agency
VETERANS AFFAIRS, DEPARTMENT OF
Sub-tier
VETERANS AFFAIRS, DEPARTMENT OF
Office
256-NETWORK CONTRACT OFFICE 16 (36C256)
General Information
Classification
Description
Contact Information
History
- Contract Opportunity Type: Special Notice (Original)
- Original Published Date: Oct 17, 2025 02:36 pm CDT
- Original Response Date: Oct 27, 2025 03:00 pm CDT
- Inactive Policy: Manual
- Original Inactive Date: Dec 26, 2025
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
-
NAICS Code:
- 621511 - Medical Laboratories
-
Place of Performance:
This is an INTENT TO SOLE SOURCE NOTICE only.
The Department of Veteran Affairs, Network Contracting Office (NCO) 16, intends to issue a sole-source contract under the authority of 41 U.S.C 253(c) (1) - FAR 6.302-1 (only one responsible source and no other supplies or services will satisfy agency requirements), to Thermofisher Scientific, 11450 Compaq Center Drive West, Houston TX 77070.
Fisher Immunosuppressant will be posted to contracting opportunities from 10/17/2025 through 10/27/2025 under NAICS 621511. This contract is to provide clinical products (Reagents, kits, and consumables) for in vitro diagnostic medical device intended for the quantitative determination of tacrolimus in human whole blood using automated clinical chemistry analyzers as an aid in the management of kidney and liver allograft patients receiving tacrolimus therapy. This is for the Southeast Louisiana Veterans Health Care Service at 2400 Canal St. New Orleans, LA 70119.
This action will result in a firm-fixed-price service contract. The period of performance shall be for November 1, 2025, to September 30, 2026 and four (4) option years that are 12 (twelve) months in length (each option year). This notice of intent is not a request for quotations; interested parties may express their interest by providing a capabilities statement not later than 10/27/2025 at 3:00 PM CST, to kimberly.anderson6@va.gov When responding to this announcement, respondents should refer to number 36C25626Q0083, Notice of Intent Fisher Immunosuppressant in the subject line. The capabilities statement must provide clear and unambiguous evidence to substantiate the capability of the party to provide the required services.
Responding as an interested party under the www.beta.sam.gov website does not constitute convincing evidence of capabilities. A determination not to compete this proposed contract upon responses to this notice is solely within the discretion of the Government. Verbal and facsimile responses are not acceptable and will not be considered. All interested parties are reminded to be registered with System for Award Management (SAM) at https://sam.gov/SAM/ in order to be eligible for award of Government contracts. No telephone calls will be accepted.
If after October 27, 2025 @ 3pm CST, no viable responses have been received in response to this announcement, NCO 16 shall negotiate solely with Thermofisher Scientific.
The Government anticipates the award of a firm-fixed-price contract. A determination by the Government whether to compete the proposed requirement shall be based upon responses received and is solely within the discretion of the government. Information received shall be considered solely for the purpose of determining whether to conduct a competition.
The Department of Veteran Affairs, Network Contracting Office (NCO) 16, intends to issue a sole-source contract under the authority of 41 U.S.C 253(c) (1) - FAR 6.302-1 (only one responsible source and no other supplies or services will satisfy agency requirements), to Thermofisher Scientific, 11450 Compaq Center Drive West, Houston TX 77070.
Fisher Immunosuppressant will be posted to contracting opportunities from 10/17/2025 through 10/27/2025 under NAICS 621511. This contract is to provide clinical products (Reagents, kits, and consumables) for in vitro diagnostic medical device intended for the quantitative determination of tacrolimus in human whole blood using automated clinical chemistry analyzers as an aid in the management of kidney and liver allograft patients receiving tacrolimus therapy. This is for the Southeast Louisiana Veterans Health Care Service at 2400 Canal St. New Orleans, LA 70119.
This action will result in a firm-fixed-price service contract. The period of performance shall be for November 1, 2025, to September 30, 2026 and four (4) option years that are 12 (twelve) months in length (each option year). This notice of intent is not a request for quotations; interested parties may express their interest by providing a capabilities statement not later than 10/27/2025 at 3:00 PM CST, to kimberly.anderson6@va.gov When responding to this announcement, respondents should refer to number 36C25626Q0083, Notice of Intent Fisher Immunosuppressant in the subject line. The capabilities statement must provide clear and unambiguous evidence to substantiate the capability of the party to provide the required services.
Responding as an interested party under the www.beta.sam.gov website does not constitute convincing evidence of capabilities. A determination not to compete this proposed contract upon responses to this notice is solely within the discretion of the Government. Verbal and facsimile responses are not acceptable and will not be considered. All interested parties are reminded to be registered with System for Award Management (SAM) at https://sam.gov/SAM/ in order to be eligible for award of Government contracts. No telephone calls will be accepted.
If after October 27, 2025 @ 3pm CST, no viable responses have been received in response to this announcement, NCO 16 shall negotiate solely with Thermofisher Scientific.
The Government anticipates the award of a firm-fixed-price contract. A determination by the Government whether to compete the proposed requirement shall be based upon responses received and is solely within the discretion of the government. Information received shall be considered solely for the purpose of determining whether to conduct a competition.
Attachments/Links
Contracting Office Address
- 715 SOUTH PEAR ORCHARD RD., PLAZA 1
- RIDGELAND , MS 39157
- USA
Primary Point of Contact
- KIMBERLY ANDERSON
- KIMBERLY.ANDERSON6@VA.GOV
- Phone Number (337) 591-9873
Secondary Point of Contact
- Oct 17, 2025 02:36 pm CDTSpecial Notice (Original)
Get Government Bids Like This by Email
Receive daily bid alerts that match your keywords, business categories, and target regions.
See Also
Follow Dapagliflozin Tablets Active Contract Opportunity Notice ID SPE2D2-26-R-0018 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Follow Progesterone Capsules Active Contract Opportunity Notice ID SPE2D2-26-R-0015 Related Notice SPE2D2-26-R-0015 Department/Ind.
DEPT OF DEFENSE
Due by 9/18/2026
Follow 65--SURVIVAL KIT,INDIVIDUA Active Contract Opportunity Notice ID SPE2DS26T414R Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Due by 9/15/2026
Follow 6505--Ticagrelor Tablets Active Contract Opportunity Notice ID 36E79726R0028 Related Notice 36E79726R0028 Department/Ind.
VETERANS AFFAIRS, DEPARTMENT OF
Due by 9/17/2026
* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.